Johnson & Johnson (JNJ) Interest & Investment Income (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Interest & Investment Income came in at $229.0 million in Q1 2026, down 31.02% year-on-year from $332.0 million in Q1 2025, and down 3.38% quarter-over-quarter from $237.0 million in Q4 2025.

Johnson & Johnson (JNJ) Interest & Investment Income (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Interest & Investment Income across 18 years of filings, most recently posting $229.0 million for Q1 2026.

  • Interest & Investment Income for Q1 2026 came in at $229.0 million, down 31.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $953.0 million (down 26.69% YoY), and the FY2025 annual result was $1.1 billion, down 20.72% from the prior year.
  • Interest & Investment Income came in at $229.0 million for Q1 2026 at Johnson & Johnson, down from $237.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $450.0 million in Q1 2023 to a low of $22.0 million in Q2 2022.
  • The 5-year median for Interest & Investment Income is $281.0 million (2024), against an average of $268.5 million.
  • Across the five-year window, Interest & Investment Income surged 1053.85% in 2022 and tumbled 34.18% in 2025, its largest moves.
  • Johnson & Johnson's Interest & Investment Income stood at $150.0 million in 2022, then soared by 142.0% to $363.0 million in 2023, then dropped by 22.59% to $281.0 million in 2024, then slipped by 15.66% to $237.0 million in 2025, then slipped by 3.38% to $229.0 million in 2026.
  • The last three Interest & Investment Income figures came in at $229.0 million (Q1 2026), $237.0 million (Q4 2025), and $227.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn 29.66 Mn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn -
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn 229.00 Mn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn -645.00 Mn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn -
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn -
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn -
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn -
10 Novartis Ag 112.59 Bn 111.90 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 229.00 Mn
Dec 28, 2025 237.00 Mn
Sep 28, 2025 227.00 Mn
Jun 29, 2025 260.00 Mn
Mar 30, 2025 332.00 Mn
Dec 29, 2024 281.00 Mn
Sep 29, 2024 292.00 Mn
Jun 30, 2024 395.00 Mn
Mar 31, 2024 364.00 Mn
Dec 31, 2023 363.00 Mn
Oct 1, 2023 374.00 Mn
Jul 2, 2023 326.00 Mn
Apr 2, 2023 198.00 Mn
Jan 1, 2023 450.00 Mn
Oct 2, 2022 150.00 Mn
Jul 3, 2022 64.00 Mn
Apr 3, 2022 22.00 Mn
Oct 3, 2021 13.00 Mn
Jul 4, 2021 12.00 Mn
Apr 4, 2021 15.00 Mn